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CHAPTER 5.2
Fungi are a heterogenous group of micro-organisms. From a clinical perspective Aspergillus
species are of special interest and have been recognized as causative organisms in human disease
since long. A,spergilli;s is able to cause infection of virtually every organ in the human body
although aspergillosis mostly presents as a pulmonary infection (chapter 1.1 and 1.2). The
different manifestations of pulmonary aspergillosis range from innocuous non-pathogenic
saprophyic colonization in healthy individuals to acute and fulminant invasive processes in
patients vulnerable to infection . Aspergillus may also act as a poweÍful allergen which may result
in the development of an allergic state in individuals with a predilection to develop allergic
sensitization (atopy) (chapter 1.2). The most pathogenic members of this genus include l.
fumigatus, A.;flavus, A. niger and A. terueus. Chapter 1.3 gives an overview of the pathology
caused by these and other I spergillus species. Chapter I .4 and chapter 1.5 describe the cellular
and humoral mechanisms that protect against Aspergillus and the fungal related factors that
facilitate A. fumigatas infection.
In recent years many researchers have focussed on the putative role of fungal proteases
in the pathogenicity of A. fumigatus. Within the Aspergillus genus, circumstantial evidence links
the production of elastinolytic proteases with the ability to cause disease. Yet, none of these
reports have conclusively demonstrated that extracellular proteases contribute significantlyto the
virulence of Aspergillus rn man. Chapter 2.2 reviews most of the in vitro and in vlvo studies on
the contribution of proteases to virulen ce of A. fumigatus. fhis chapter also presents two models
for the role of proteases in human disease. Basically, the first model states that proteases ecreted
by Aspergillus tnduce a self perpetuating cycle of inflammation at the airway epithelium by
causing epithelial cell desquamation and inducing release of pro-inflammatory cytokines from
the epithelial cells. These pro-inflammatory cytokines may subsequently call in inflammatory
cells followed by processes that cause further damage of the epithelium, thereby creating a site
for fungal attachment and infiltration. Damage of the epithelium causes further development of
inflammation. An alternative hypothesis states that proteases play a role in early events related
to infection. The airway epithelium constitutes a tight banier between the internal and external
environment, therefore, one of the prime targets for the fungus may be the epithelial cellbanier.
Here, fungal proteases may become important in their ability to induce epithelial cell
desquamation.
In this thesis the contribution of proteases to the pathogenicity was studied in different
ways. To ascertain the release of proteases in patients with aspergillosís in vivo, we studied the
IgG antibody production specific for fungal proteases in sera from patients with ABPA and PA
(chapter 2.3). Routine fungal culture media do not favor protease production therefore l.
fumigatus was cultured on collagen medium, resulting in the excretion of high levels of fungal
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protease activity. Protein profiles of collagen medium filtrate show several proteins not found
inconventional culture filtrates, including aprominent 32kD glycoprotein, which coisolates with
elastase activity, as well as 67 kD and 94 kD proteins. These constituents elicit IgG production
in patients with ABPA and PA, suggesting production of these proteins during disease in vivo.
As was discussed before, the epithelium is essential in the protection against pathogens
by its function as a physical barrier. In recent years evidence has been presented indicating a role
of airway epithelial cells in the orchestration of local inflammatory responses. To investigate
whether fungal proteases could induce an inflammatory response or cause loss of the barrier
function of the epithelium, the production of pro-inflammatory cy.tokines and epithelial cell
desquamation i  respons to protease-containingA.fumigaras culture filtrates was studiedinvitro
(chapter 2.4).lt was found that fungal serine protease activity induced the production of IL-8,
IL-6 and MCP-l and caused cell desquamation i a dose-dependent fashion. Both phenomena
were inhibited by serine protease inhibitors including ALP. By causing cell desquamation, fungal
proteases may decrease the physical barrier function of the epithelium; however, by eliciting a
cytokine response, the epithelium may signal the mucosal inflammatory response against l.
fumigatus.
Chapter 2.5 presents further studies on the induction of a pro-inflammatory cytokine
response and cell desquamation in airway epithelial cells with mite (Lepidoglyphus destructor
and, Dermatophagoides pteronyssinus), Timothy grass pollen and birch pollen extracts.
Production of IL-8. IL-6, MCP-I and GM-CSF and cell detachment were monitored in
pulmonary epithelial cell lines and primary epithelial cell cultures from the nose. With the mite
extracts, cytokine production and cell detachment was largely dependent on protease activity.
With the pollen extracts cytokine production without cell detachment seemed to be protease-
independent. Results from this study are of special interest since the factors responsible for
inducing or maintaining allergic airway inflammation in patients with asthma and rhinitis are
poorly understood. The observation of local airway inflammation in non-allergic patients with
asthma or rhinitis including those with nasal polyposis suggests that 'non-IgE-related'
mechanisms exist that may lead to airway inflammation. The findings presented in chapter 2.5
support he view that epithelial cells contribute to the pathogenesis of airway disease by their
interaction with inhalant allergen extracts. Furthermore, allergen extracts may enhance airway
inflammation by means other than their lgE-binding activity via protease-dependent and -
independent mechanisms.
Opposing the fungus, the human defense system tries to deal with potentially life-
threatening micro-organisms. Both the adaptive and the native immune systems have been
studied extensively for the past decades. Recent findings have suggested a role for ALP in the
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mucosal defense against bacteria. ALP is a major protease inhibitor of mucous secretions and,
in the human lung, is produced locally by various cell types including those from the lining
epithelium. Based on previous findings on the antibacterial activity of ALP we studied its
antifungal activity towards A. fumigatas and C. albicans (chapter 3.2). rALP had pronounced
fungicidal activity toward metabolically active A. fumigatzs conidia and C. albicans yeast cells;
however, metabolically quiescentA. fumigatus conidia were totally resistant. In contrast with the
protease inhibitory activity of rALP, the fungicidal activity was found to be localized primarily
in the NHr-terminal domain. On a molar base, the fungicidal activity of rALP was comparable
with that of human defensins and lysozyme and is probably related to the cationic nature of the
protein. In addition, rALP caused inhibition of C. albicans yeast cell growth. By exhibiting
antifungal activity ALP may play an important role in the innate mucosal defense against human
pathogenic fungi. Chapter 3.3 discusses the potential of ALP as a therapeutic option in the
treatment of infectious diseases in view of the unpropitious development of drug resistance of
infectious micro-organisms in the human population.
Many studies have focussed on IgG antibody responses in different diseases, however,
the factors that lead to increased production of specific IgG subclasses in aspergillosis are still
largely unknown. Of particular interest is the role of IgG4 in immune responses. It has been
suggested that IgG4 is a marker of protection against allergy. Others suggest hat IgG4 is a
marker of chronic antigen exposure, and it may play a role in protecting the host from protracted
inflammatory reactions. Chapter 3.4 presents results from studies on IgG subclass production
in patients with ABPA and PA as models of transient and chronic exposure to Aspergillus
antigens, respectively. Increased IgG4 responses were found under conditions of chronic
exposure to A. fumigatus antrgen. A. fumigatus-specific-lgGl was increased in patients with PA
compared with those in patients with ABPA. Patients with PA having IgE responses to l.
fumigatus and/or other inhalant allergens howed significantlyhigherl . fumigatus-specific-IgG4
responses than patients with PA having negative IgE responses or patients with ABPA,
Surveillance studies over time in individual patients showed that both the A. fumigalas-specific-
IgGl and IgG4levels followed the course of disease progression and treatment. Immunoblotting
revealed correlations between A. fumigatr.rs-specific-IgGl and IgG4 binding to most, but not all,
antigenic,,4 .fumigatus components. This study documents forthe firsttime increased IgG4levels
under conditions of chronic exposure to fungal antigen in PA and a significantly higher IgG4
response in those patients with PA who produce tgE. The transient exposure to A. fumigatus







In addition to studies on the more fundamental processes that underlie pathogenicity of
Aspergillus and the human host defense, diagnosis of fungal infection in patients with
aspergillosis i  of major importance from a clinical point of view. Aspergillosis may present as
a highly destructive disease with grave prognosis especially in patients who are
immunocompromised. Diagnosis may be difficult to reach in some patients underlining the need
for diagnostic tools. Early diagnosis of fungal infections is of crucial importance to limit fungal
tissue invasion and irreversible tissue destruction. In chapter 4 two studies are presented on the
evaluation of the IgG-antibody responses in the serodiagnosis of Aspergillus infection in
immunocompetent and immunocompromised patients. Chapter 4.2 describes the monitoring of
disease and treatment in an immunocompetent patient with exacerbations of PA during a9-year
follow-up. A rise in IgG response as identified by ELISA coincided with a recrudescence of
clinical symptoms whereas a decrease in IgG response after treatment paralleled clinical
improvement. IgG-binding to the 32kD serine protease, and to 60 and 94 kD proteins produced
with collagen-containing culture medium closely corresponded with IgG-ELISA titers. igG-
binding to a 40 kD metalloprotease remained at very low levels until symptoms and fungal
growth became well advanced, when a sharp rise was seen. Responses to all antigens rapidly
diminished after the start of successful antifungal treatment with itraconazole. Serology may be
a useful adjunct in the monitoring of disease progression and the efficacy of antifungal treatment
in patients with PA. Immunologic responses to fungal proteases raised with collagen-containing
culture media may reflect fungal proteolytic involvement during disease progression and
treatment more closely than responses to proteins raised with conventional media.
Finally, chapter 4.3 presents data from a retrospective study on the serodiagnosis of
aspergillosis in immunocompromised patients after lung transplantation. Four patients from the
center for lung transplantation from the University Hospital Groningen were included in the
study. All patients had proven A. fumigalas infections after lung transplantation and fatal
outcome. The IgG antibody response specific for A. fumigatus antrgens raised with conventional
media was measured by means of ELISA and compared with radiographic features, cytologic
findings, microbiological cultures, and clinical diagnosis. Increasing IgG antibody responses
closely paralleled cy'tologic or microbiological identification of A. fumigatus from
bronchoalveolar lavage fluid and decrease of lung function. Increasing specific IgG antibody
responses were found to precede radiographic identification of lung cavitation by 1 to 2 wk, to
precede the diagnosis of aspergillosis by 2 to 20 wk, and to detect fungal reinfection. In most
cases, successful antifungal treatment decreased specific IgG antibody response. A decrease in
specific IgG antibody response correlated with the inability to culture or identify A.fumigatus
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from bronchoalveolar lavage fluid and with radiographic and clinical improvement. IgG antibody
responses in serum may, therefore, provide important information that is helpful in the diagnosis
and early treatment of pulmonary fungal infections and in monitoring antifungal treatment in
patients who have had lung transplantation.
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